Tri-Cira 28 0.035 mg (Ethinyl Estradiol TABLET) 0.035 MG

TRI-CIRA 28 0.035 MG is an oral contraceptive tablet containing ethinyl estradiol. It is commonly used for birth control and may help regulate menstrual cycles. This medication is manufactured by Apotex Inc. in Canada.

Strength

0.035 MG

Manufacturer / TM Owner

APOTEX INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

TRI-CIRA 28 0.035 MG is primarily used as a hormonal contraceptive to prevent pregnancy. It works by altering the cervical mucus and uterine lining to inhibit ovulation. Some individuals may also use this medication to manage menstrual irregularities or reduce symptoms of premenstrual syndrome. Always consult a healthcare provider to determine if this medication is suitable for your needs.

Side Effects

Common effects of TRI-CIRA 28 0.035 MG may include changes in menstrual bleeding patterns, such as lighter or more regular periods. Some users may experience breast tenderness, headaches, or nausea. These effects vary among individuals and typically subside as the body adjusts to the medication. If any effects are severe or persistent, it is important to seek medical advice.

Precautions & Warnings

TRI-CIRA 28 0.035 MG should be used with caution, especially for individuals with a history of blood clots, high blood pressure, or certain types of cancer. It is important to inform your healthcare provider about any pre-existing conditions or allergies before starting this medication. Regular follow-ups may be necessary to monitor for any adverse effects.

Avoid Interactions

TRI-CIRA 28 0.035 MG may interact with certain medications, including antibiotics, anticonvulsants, and HIV medications. Alcohol consumption should be moderated, as it can increase the risk of side effects. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.

Frequently Asked Questions

TRI-CIRA 28 0.035 MG is primarily used as an oral contraceptive to prevent pregnancy and may also help regulate menstrual cycles.

TRI-CIRA 28 0.035 MG should be taken orally, typically once daily, as directed by a healthcare provider.

Common side effects may include changes in menstrual bleeding, breast tenderness, headaches, and nausea.

TRI-CIRA 28 0.035 MG may interact with certain medications, so it is important to consult a healthcare provider before combining it with other treatments.

TRI-CIRA 28 0.035 MG should be used with caution, especially for individuals with a history of blood clots, high blood pressure, or certain types of cancer.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.